According to Vertex Pharmaceuticals's latest financial reports the company's total debt is $0.80 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.80 B | -10.15% |
2022-12-31 | $0.89 B | -7% |
2021-12-31 | $0.96 B | 3.81% |
2020-12-31 | $0.93 B | 40.84% |
2019-12-31 | $0.66 B | 12.75% |
2018-12-31 | $0.58 B | -3.23% |
2017-12-31 | $0.60 B | -27.87% |
2016-12-31 | $0.84 B | 1.76% |
2015-12-31 | $0.82 B | 0.16% |
2014-12-31 | $0.82 B | 62.85% |
2013-12-31 | $0.50 B | -27.31% |
2012-12-31 | $0.69 B | 52.85% |
2011-12-31 | $0.45 B | -15.09% |
2010-12-31 | $0.53 B | 249.07% |
2009-12-31 | $0.15 B | -46.49% |
2008-12-31 | $0.28 B | 1337.72% |
2007-12-31 | $19.99 M | -83.84% |
2006-12-31 | $0.12 B | -31.28% |
2005-12-31 | $0.18 B | -46.24% |
2004-12-31 | $0.33 B | 0.46% |
2003-12-31 | $0.33 B | 1.62% |
2002-12-31 | $0.32 B | 0.16% |
2001-12-31 | $0.32 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 3,528.40% | ๐บ๐ธ USA |
AbbVie ABBV | $59.38 B | 7,245.99% | ๐บ๐ธ USA |
Gilead Sciences GILD | $24.98 B | 2,990.92% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 4,236.34% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $41.46 B | 5,029.14% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $25.49 M | -96.85% | ๐บ๐ธ USA |